A generic pharmaceutical manufacturer, Glenmark Pharmaceuticals Inc. USA (Glenmark), located in Mahwah, New Jersey, has agreed to pay $25 million, based on its ability to pay, to resolve its alleged liability under the False Claims Act for conspiring to fix the price of a generic drug. Read More
Home » Pharmaceutical Company Pays $25M to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drug
Pharmaceutical Company Pays $25M to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drug
Related Posts
Afghan National Pleads Guilty to Obtaining Firearms in Connection with
Abdullah Haji Zada, 18, a native and citizen of Afghanistan and U.S. lawful permanent resident, pleaded guilty today to a criminal information charging him with… BronAfghan National Pleads Guilty to Obtaining Firearms in Connection with
Former President of Asphalt Paving Company Receives Prison Sentence
A former senior executive of a Michigan asphalt paving company was sentenced today to six months in prison and a $20,000 fine for his role… BronFormer President of Asphalt Paving Company Receives Prison Sentence
Federal Judge Finds a Virginia Man Guilty of Child Pornography
Yesterday, a district court judge convicted a Virginia man, who worked for the Department of Commerce, of possessing and receiving child sexual abuse material (CSAM).… BronFederal Judge Finds a Virginia Man Guilty of Child Pornography